Growth vs Value Investing

Growth investing buys companies growing revenue and earnings faster than the market average, typically technology and healthcare names that reinvest every dollar instead of paying a dividend. The valuation shows the trade: growth stocks carry higher price-to-earnings ratios, because the market pays up front for years of expansion that have not happened yet. The style's benchmark is the Russell 1000 Growth index. Value investing buys companies trading below a measure of worth, screened by low price-to-earnings ratios, low price-to-book ratios, and high dividend yields. Its benchmark is the Russell 1000 Value index, and its lineage runs from Benjamin Graham through Warren Buffett.

In the US the two styles are packaged into index funds, so the choice is usually a fund decision rather than a stock-picking one. The performance history is the humbling part: value beat growth for most of the twentieth century, growth crushed value in the 2010s, value won 2022, and growth won 2023 by double digits in a single year. Neither style owns a permanent edge, and the rotation between them is the reason most diversified portfolios hold both.

The two styles are screening systems applied to the same market. A growth screen ranks companies by earnings and revenue growth and accepts high multiples as the price of the expansion: a price-to-earnings ratio of 35 is affordable if earnings compound 20% a year, because the multiple compresses as the earnings arrive. A value screen ranks the same companies by how cheaply they trade, using low price-to-earnings, low price-to-book, and high dividend yield, and the bet is that the discount closes. One style buys the future arriving on schedule; the other buys the market being wrong about the present.

The styles meet in one number, the PEG ratio: the price-to-earnings ratio divided by the growth rate. A growth stock at a P/E of 30 growing 30% a year carries a PEG of 1.0, the same as a value stock at a P/E of 10 growing 10% a year. The ratio is a hypothesis test rather than a verdict, because growth rates are forecasts and forecasts fail. That is the structural asymmetry: value's mistake is buying a company that deserves its discount, and growth's mistake is paying a price that assumes perfection.

In practice most American investors run the styles through funds: Russell 1000 Growth and Russell 1000 Value ETFs hold each side at index weights. The performance record decides nothing in advance. Value outperformed across much of the twentieth century, lost the 2010s decisively, won 2022 as rising rates crushed long-duration growth stocks, and lost 2023 by double digits in a single year. The rotation, not either style alone, is the feature.

The choice matters because the two styles fail differently. Growth portfolios fall hardest in rising-rate years and recessions of expectation; value portfolios fall when the economy itself breaks, because banks, energy, and industrials are its backbone. In 2022 the Russell 1000 Value index fell roughly 8% while the growth index fell 29%, and in 2023 the same growth index rose 42% while value rose 11%. Judging one style in its bad year is how investors buy high and sell low with extra steps.

I watched a colleague named Brent (yes, that Brent) sell his value fund in early 2021 after a decade of growth winning without him, and buy a technology-heavy growth fund at the top. The fund fell roughly 30% in 2022 in the rotation he sold the day before. He had switched styles at the exact moment the decade of underperformance was ending, which is the standard outcome of chasing whichever style won last.

The highest-leverage thing most Americans can do is hold both through a broad total-market index fund, which owns growth and value at market weights and never has to call the turn. Investors who want the tilt can add it as a satellite, sized so a decade of being wrong is survivable. Check the valuation inputs with the P/E ratio calculator and project the compounding with the investment calculator.